Today: 17 April 2026
Strategy (MSTR) stock drops as bitcoin slips; traders eye new BTC buy and pricey funding
4 March 2026
1 min read

Strategy (MSTR) stock drops as bitcoin slips; traders eye new BTC buy and pricey funding

NEW YORK, March 3, 2026, 18:12 EST — After-hours

  • Strategy shares ended Tuesday down 3.6%, despite a sharp move earlier in the day.
  • The latest filing showed a fresh bitcoin buy, this time bankrolled by selling stock. There’s also a higher dividend coming for holders of that high-yield preferred.
  • Bitcoin’s direction is on investors’ radar, along with the company’s dividend schedule for March.

Strategy Inc dropped 3.6% to finish at $132.68 Tuesday. Shares touched a low of $127.86 and hit $136.42 at the session’s high. Bitcoin slipped roughly 0.9%, last seen at $68,654, having moved between $66,326 and $69,291 earlier.

What’s notable here: Strategy has stopped behaving like your typical software stock and now looks more like a proxy for bitcoin’s swings. The shares tend to jump or dive with the token, and investors are quick to drop questions about the size of their bitcoin purchases in favor of scrutinizing funding methods.

Strategy disclosed in a Monday Form 8-K that it picked up 3,015 bitcoin between Feb. 23 and March 1, paying roughly $204.1 million. The company financed the purchase using net proceeds, including $229.9 million from the sale of 1.73 million common shares and another $7.1 million from unloading 71,590 shares of its variable-rate preferred (STRC). The filing also noted STRC’s annual dividend is moving up to 11.50% from 11.25%, effective with monthly periods beginning March 1.

Michael Saylor, Executive Chairman, didn’t mince words on X. He posted that Strategy “has acquired 3015 BTC” and now “hodl” 720,737 bitcoin as of March 1. X (formerly Twitter)

An at-the-market program, or “ATM,” gives a company the option to drip shares into the market in small amounts, rather than unloading a large block all at once. That flexibility can help raise capital, but current shareholders may see dilution—and when shares already trade lower, selling more can make the math even less appealing.

Shares tied to crypto drifted mostly lower as bitcoin slipped. Coinbase dropped 1.6%. Marathon Digital slid 8.3%, with Riot Platforms losing 6.9%. Grayscale Bitcoin Trust fell 1.3%.

Strategy Inc — the company previously called MicroStrategy — switched over to its new name in August 2025. The business continues to offer software, though investors usually zero in on its bitcoin “treasury,” the stash of tokens listed on its balance sheet. Yahoo Finance

Speed remains the wild card. Should bitcoin tumble sharply, Strategy’s shares are likely to sink even faster. The company could be pushed to turn more to equity offerings or pricier preferreds just to stay in the bitcoin-buying game. Selling investors on that idea gets trickier when the dividend tab is already on everyone’s mind.

The company’s preferred dividend dates for March are locked in: March 15 for the record, March 31 for the payout, according to the filing. Traders are eyeing the next updates on stock sales and fresh bitcoin buys.

Stock Market Today

  • Nufarm ASX Share Rises on Strong 2026 EBITDA Guidance despite Lower Forecast
    April 16, 2026, 10:07 PM EDT. Nufarm (ASX: NUF) issued first-half fiscal 2026 underlying EBITDA guidance of $239-$244 million, marking a 17% increase from 2025 but below prior $265 million forecasts. Shares jumped 11% on the positive outlook. Gains stem from better crop protection margins, hybrid seed growth, omega-3 recovery, and bioenergy segments. Net debt fell 10% to $1.2 billion, with a net debt to EBITDA ratio of 2.4, improving by 20%. The company expects full-year net debt/EBITDA below 2.0. Despite challenges from previous omega-3 losses and competitive global markets, Nufarm's shares trade at a discount to its $3.50 fair value, reflecting a 16% EBITDA CAGR through 2030. Demand growth in sustainable agriculture and emerging markets underpins its expansion and profitability prospects.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
MongoDB stock plunges after forecast miss; analysts slash targets before Morgan Stanley conference
Previous Story

MongoDB stock plunges after forecast miss; analysts slash targets before Morgan Stanley conference

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom
Next Story

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom

Go toTop